Price$14.97-0.26 (-1.74%)
01:45 PM07:45 PM
News · 26 weeks51+38%
2025-12-142026-06-07
Mix2490d
- Insider14(58%)
- SEC Filings5(21%)
- Earnings4(17%)
- Other1(4%)
Latest news
25 items- INSIDERDirector Dunn Jeffrey W was granted 10,957 shares and sold $54,505 worth of shares (3,575 units at $15.25), increasing direct ownership by 75% to 16,057 units (SEC Form 4) to cover withholding tax4 - SI-BONE, Inc. (0001459839) (Issuer)
- INSIDERDirector Nishimura Mika was granted 10,957 shares, increasing direct ownership by 33% to 43,673 units (SEC Form 4)4 - SI-BONE, Inc. (0001459839) (Issuer)
- INSIDERDirector West Thomas A. was granted 10,957 shares, increasing direct ownership by 41% to 37,947 units (SEC Form 4)4 - SI-BONE, Inc. (0001459839) (Issuer)
- INSIDERDirector Freund John Gordon was granted 10,957 shares, increasing direct ownership by 25% to 54,258 units (SEC Form 4)4 - SI-BONE, Inc. (0001459839) (Issuer)
- INSIDERDirector Davis Timothy E Jr was granted 10,957 shares, increasing direct ownership by 17% to 76,679 units (SEC Form 4)4 - SI-BONE, Inc. (0001459839) (Issuer)
- SECSI-BONE Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits8-K - SI-BONE, Inc. (0001459839) (Filer)
- PRSI-BONE To Present at Truist Securities 2026 MedTech Conference on June 16, 2026SANTA CLARA, Calif., June 04, 2026 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (NASDAQ:SIBN), the global leader in developing procedural solutions to address clinical challenges associated with compromised bone, today announced that the company will be participating in the upcoming 2026 Truist Securities MedTech Conference in Boston, MA. Management will be hosting a fireside chat on Tuesday, June 16, 2026, at 5:40 a.m. Pacific Time/ 8:40 a.m. Eastern Time. Investors interested in listening to the conference call may do so by registering at this link: https://event.summitcast.com/view/b4rPMsFmx6FA94q8B8jb82. Live audio of the webcast will be available on the "Investors" section of the company's webs
- INSIDERDirector Davis Timothy E Jr exercised 12,064 shares at a strike of $4.32 and sold $104,187 worth of shares (7,280 units at $14.31), increasing direct ownership by 8% to 65,722 units (SEC Form 4)4 - SI-BONE, Inc. (0001459839) (Issuer)
- INSIDERChief Executive Officer Francis Laura sold $220,000 worth of shares (14,957 units at $14.71), decreasing direct ownership by 8% to 503,444 units (SEC Form 4) to cover withholding tax4 - SI-BONE, Inc. (0001459839) (Issuer)
- INSIDERSVP, Ops & Adm/Chief Legal Ofr Pisetsky Michael A. sold $54,527 worth of shares (3,726 units at $14.63), decreasing direct ownership by 0.82% to 280,509 units (SEC Form 4) (tax liability)4 - SI-BONE, Inc. (0001459839) (Issuer)
- INSIDERChief Financial Officer Maheshwari Anshul sold $68,523 worth of shares (4,666 units at $14.69), decreasing direct ownership by 1% to 259,877 units (SEC Form 4) to cover withholding tax4 - SI-BONE, Inc. (0001459839) (Issuer)
- SECSEC Form 10-Q filed by SI-BONE Inc.10-Q - SI-BONE, Inc. (0001459839) (Filer)
- SECSI-BONE Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - SI-BONE, Inc. (0001459839) (Filer)
- PRSI-BONE, Inc. Reports Financial Results for the First Quarter 2026 and Raises 2026 GuidanceFirst Quarter 2026 Financial Highlights (all comparisons are to the prior year period) Worldwide revenue of $52.6 million, representing growth of 11.2%U.S. revenue of $49.3 million, representing growth of 10.0%Gross margin of 79.8% Net loss of $4.3 million, representing an improvement of 33.8% Adjusted EBITDA of $2.5 million, representing an improvement of over 440%$144.7 million in cash and equivalents Recent Operational Highlights (any comparisons are to the prior year period) Over 1,650 active U.S. physicians, representing growth of 17% $2.2 million in trailing 12-month average revenue per territory, representing an increase of 11%Expanded international presence with the launch
- INSIDERDirector Dunn Jeffrey W sold $4,432 worth of shares (337 units at $13.15), decreasing direct ownership by 4% to 9,157 units (SEC Form 4) to satisfy withholding tax4 - SI-BONE, Inc. (0001459839) (Issuer)
- PRSI-BONE To Present at BofA Securities 2026 Healthcare Conference on May 12, 2026SANTA CLARA, Calif., April 30, 2026 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (NASDAQ:SIBN), the global leader in developing procedural solutions to address clinical challenges associated with compromised bone, today announced that the company will be participating in the upcoming 2026 BofA Securities Healthcare Conference in Las Vegas, NV. Management will be hosting a fireside chat on Tuesday, May 12, 2026, at 8:00 a.m. Pacific Time/11:00 a.m. Eastern Time. Investors interested in listening to the conference call may do so by registering at this link: https://bofa.veracast.com/webcasts/bofa/healthcare2026/f3F578.cfm. Live audio of the webcast will be available on the "Investors" section of the c
- SECSEC Form DEFA14A filed by SI-BONE Inc.DEFA14A - SI-BONE, Inc. (0001459839) (Filer)
- SECSEC Form DEF 14A filed by SI-BONE Inc.DEF 14A - SI-BONE, Inc. (0001459839) (Filer)
- PRSI-BONE To Report First-Quarter 2026 Financial Results on May 11, 2026SANTA CLARA, Calif., April 20, 2026 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (NASDAQ:SIBN), the global leader in developing procedural solutions to address clinical challenges associated with compromised bone, today announced it will report financial results for the first quarter of 2026 after market close on Monday, May 11, 2026. Management will host a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time Investors interested in listening to the conference call may do so by registering at this link: https://edge.media-server.com/mmc/p/vde24u4q. Live audio of the webcast will be available on the "Investors" section of the company's website at: www.si-bone.com. The webcast
- INSIDERSEC Form 4 filed by Hinckley Greg K4 - SI-BONE, Inc. (0001459839) (Issuer)
- INSIDERSEC Form 4 filed by Maheshwari Anshul4 - SI-BONE, Inc. (0001459839) (Issuer)
- INSIDERSEC Form 4 filed by Pisetsky Michael A.4 - SI-BONE, Inc. (0001459839) (Issuer)
- SECAmendment: SEC Form SCHEDULE 13G/A filed by SI-BONE Inc.SCHEDULE 13G/A - SI-BONE, Inc. (0001459839) (Subject)
- INSIDERDirector Nishimura Mika sold $56,700 worth of shares (4,100 units at $13.83), decreasing direct ownership by 11% to 32,716 units (SEC Form 4)4 - SI-BONE, Inc. (0001459839) (Issuer)
- SECSEC Form S-8 filed by SI-BONE Inc.S-8 - SI-BONE, Inc. (0001459839) (Filer)
SIBN FAQ
7 questionsWhat does SI-BONE Inc. do?
SI-BONE, Inc., a medical device company, develops implantable devices used in the surgical treatment of the sacropelvic anatomy in the United States and Internationally. The company offers iFuse, a minimally invasive surgical implant system, which is intended to fuse the sacroiliac joint to treat sacroiliac joint dysfunction that causes lower back pain. SI-BONE, Inc. was incorporated in 2008 and is headquartered in Santa Clara, California.Where does SIBN stock trade?
SI-BONE Inc. (SIBN) is listed on NASDAQ.What sector and industry is SIBN in?
SI-BONE Inc. operates in the Health Care sector, Medical/Dental Instruments industry.When did SI-BONE Inc. go public?
SI-BONE Inc. (SIBN) completed its IPO in 2018.What are analysts saying about SIBN?
SI-BONE Inc. has had 8 recent analyst actions on file. The most recent action was from TD Cowen: Buy with a $2100.00 price target on 2026-01-27. Recent price targets range from $1900.00 to $3600.00.What companies are similar to SIBN?
Notable peers in the same industry include SYK (Stryker Corporation), MMM (3M Company), BSX (Boston Scientific Corporation), MDLN (Medline Inc.), BDX (Becton Dickinson and Company). Compare SIBN side-by-side with any of them on Quantisnow.How can I track SIBN on Quantisnow?
Quantisnow aggregates SI-BONE Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow SIBN to receive live email and push alerts on every new disclosure.